Umut A. Gurkan

Biochip Labs, Inc.

NIH Rank #7097
  • Program Leader
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
4
Active NIH grants
National Rank
#7,097
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.7M across 4 grants · National rank #7097.

Top grants by award amount

Umut A. Gurkan's NIH grant portfolio, ranked by award amount.

  • 5R42HL162214-03R42
    Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability
    $865.4K
    award amount
  • 5U01AI176469-02U01
    A Modality-Agnostic Potency Assay Enabling Both Ex Vivo and In Vivo Genome Editing Therapeutics for Sickle Cell Disease
    $471.4K
    award amount
  • 1R41HL172662-01R41
    RHODA: Rapid Hemoglobin-Oxygen Dissociation Assay
    $295.9K
    award amount
  • 3R42HL162214-03S1R42
    Microfluidic Technology for Concurrent Assessment of Red Blood Cell Adhesion and Deformability (Administrative Supplement)
    $70.8K
    award amount

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Biochip Labs, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7097
  5. 2024
    Multi-Institutional Research
    Awards at 3 institutions

Related investigators

Other NIH-funded PIs frequently associated with Umut A. Gurkan.